Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Sell

C

2seventy bio, Inc. Common Stock (TSVT)

Pharmaceutical Preparations

https://www.2seventybio.com

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

60 BINNEY STREET
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/18/2021

Market Cap

235,436,824

Shares Outstanding

50,630,000

Weighted SO

50,624,606

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

ICPT --.--%

PBYI --.--%

IOVA --.--%

SRPT --.--%

DAWN --.--%

INZY --.--%

ZNTL --.--%

SNDX --.--%

PTGX --.--%

Beta

1.7810

Last Div

0.0000

Range

1.535-6.4

Chg

-0.0100

Avg Vol

484225

Mkt Cap

235436824

Exch

NASDAQ

Country

US

Phone

339 499 9300

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

5.3363

EV Multiple

-2.4062

P/FV

1.0179

Div Yield %

0.0000

P/E

-1.5296

PEG

-0.0615

Payout

0.0000

Current Ratio

4.7638

Quick Ratio

4.7638

Cash Ratio

2.3698

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

47.7974

CCC

-47.7974

Gross Margin

0.4816

Op Margin

-4.6886

Pretax Margin

-3.5416

Net Margin

-3.5416

Eff Tax Rate

-0.0617

ROA

-0.3017

ROE

-0.6225

ROCE

-0.4395

NI/EBT

1.0000

EBT/EBIT

0.7554

EBIT/Rev

-4.6886

Debt Ratio

0.4854

D/E

1.0707

LT Debt/Cap

0.5012

Total Debt/Cap

0.5171

Int Coverage

-44.7844

CF/Debt

-0.5972

Equity Multi

2.2057

Rec Turnover

0.0000

Pay Turnover

7.6364

Inv Turnover

0.0000

FA Turnover

0.1785

Asset Turnover

0.0852

OCF/Share

-2.8767

FCF/Share

-2.9627

Cash/Share

3.8683

OCF/Sales

-3.4027

FCF/OCF

1.0299

CF Coverage

-0.5972

ST Coverage

-9.6812

CapEx Coverage

-33.4505

Div&CapEx Cov

-33.4505

P/BV

1.0179

P/B

1.0179

P/S

5.3363

P/E

-1.5296

P/FCF

-1.5227

P/OCF

-1.5921

P/CF

-1.5921

PEG

-0.0615

P/S

5.3363

EV Multiple

-2.4062

P/FV

1.0179

DPS

0.0000

Latest Headlines (EST)

Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Benzinga Dec 19, 17:05 Russell 2000 Rallies To 16-Month Highs: Best Performing Small-Cap Stocks Popping Over 80% In December PennyStocks Dec 06, 14:48 Best Penny Stocks To Buy? 4 To Watch With Big News This Week PennyStocks Dec 06, 14:48 Best Penny Stocks To Buy? 4 To Watch With Big News This Week MarketWatch Nov 20, 15:05 Dow Jones climbs, S&P 500 aims to exit correction on hopes the Fed is finished raising rates MarketWatch Nov 20, 12:54 Dow Jones climbs, S&P 500 aims to exit correction on hopes the Fed is finished raising rates MarketWatch Nov 20, 12:23 Dow Jones climbs, S&P 500 aims to exit correction on hopes the Fed is finished raising rates MarketWatch Nov 20, 10:27 Dow Jones trades near 2-month high amid optimism Fed is finished raising rates Zacks Investment Research Nov 02, 02:48 CRISPR Therapeutics AG (CRSP) Surges 12.4%: Is This an Indication of Further Gains?

Revenue Product Segmentation